Article
AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction
2025-08-25
Abstract excerpt
Alzheimer’s disease (AD), the leading cause of dementia, is characterized by early synaptic dysfunction that precedes overt cognitive decline. While amyloid-β and Tau remain central to AD pathogenesis, molecular triggers of synapse weakening remain unclear. Here, we investigated AETA, a novel brain-secreted peptide derived from amyloid precursor protein (APP), as a potential mediator of synapse dysfunction in AD....
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Computational Drug Discovery Methods
- Estrogen and related hormone effects
- Menopause: Health Impacts and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroscience and Neuropharmacology Research
- Nuclear Receptors and Signaling
- Tryptophan and brain disorders
Identifiers and source
- Literature Corpus work
- c441845a-1be1-530c-b34d-330b90f82aa5
- DOI
- 10.1101/2025.08.22.671719
